U.S. markets closed
  • S&P Futures

    4,167.25
    +7.25 (+0.17%)
     
  • Dow Futures

    34,179.00
    +61.00 (+0.18%)
     
  • Nasdaq Futures

    13,525.50
    +34.50 (+0.26%)
     
  • Russell 2000 Futures

    2,245.20
    +8.60 (+0.38%)
     
  • Crude Oil

    65.54
    -0.09 (-0.14%)
     
  • Gold

    1,786.10
    +1.80 (+0.10%)
     
  • Silver

    26.50
    -0.03 (-0.10%)
     
  • EUR/USD

    1.2011
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.5840
    -0.0080 (-0.50%)
     
  • Vix

    19.15
    -0.33 (-1.69%)
     
  • GBP/USD

    1.3910
    +0.0002 (+0.01%)
     
  • USD/JPY

    109.3200
    +0.1310 (+0.12%)
     
  • BTC-USD

    57,088.28
    +2,435.40 (+4.46%)
     
  • CMC Crypto 200

    1,466.71
    +61.41 (+4.37%)
     
  • FTSE 100

    7,039.30
    +116.13 (+1.68%)
     
  • Nikkei 225

    29,326.96
    +514.33 (+1.79%)
     

Bristol-Myers Squibb (BMY) Catches Eye: Stock Jumps 6.8%

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Bristol-Myers Squibb Company BMY was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 11.4% in the past one-month time frame.

The company has seen two positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few weeks, suggesting that more solid trading could be ahead for Bristol-Myers Squibb. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Bristol-Myers Squibb currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive. 

Bristol Myers Squibb Company Price

Bristol Myers Squibb Company Price
Bristol Myers Squibb Company Price

Bristol Myers Squibb Company price | Bristol Myers Squibb Company Quote

A better-ranked stock in the Medical - Biomedical and Genetics industry is Avid Bioservices, Inc CDMO, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report
 
Avid Bioservices, Inc. (CDMO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research